epigallocatechin gallate has been researched along with Pneumonia, Bacterial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jian, S; Li, L; Li, W; Li, Y; Shi, F; Song, X; Tang, H; Wang, Y; Ye, G; Yin, Z; Zhao, L; Zhao, X; Zou, Y | 1 |
| Bedugnis, AS; Biswal, S; DeLoid, GM; Gibbons, JG; Kobzik, L; Thimmulappa, RK; Wu, M | 1 |
2 other study(ies) available for epigallocatechin gallate and Pneumonia, Bacterial
| Article | Year |
|---|---|
Epigallocatechin-3-gallate ameliorates liver injury secondary to Pseudomonas aeruginosa pneumonia.
Topics: Alanine Transaminase; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Catechin; Cytokines; Interleukin-6; Liver; Liver Diseases; Mice; Myeloid Differentiation Factor 88; NF-kappa B; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2022 |
Immunomodulators targeting MARCO expression improve resistance to postinfluenza bacterial pneumonia.
Topics: Animals; Base Sequence; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Bronchoalveolar Lavage Fluid; Catechin; Cell Line; Cytokines; Disease Resistance; Host-Pathogen Interactions; Humans; Immunologic Factors; Influenza, Human; Interferon-gamma; Isothiocyanates; Macrophages, Alveolar; Male; MAP Kinase Kinase Kinases; Mice, Inbred C57BL; Models, Biological; Orthomyxoviridae Infections; Phagocytosis; Pneumonia, Bacterial; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Receptors, Immunologic; RNA, Messenger; Sequence Analysis, RNA; Signal Transduction; Staphylococcus aureus; Sulfoxides; Up-Regulation | 2017 |